Kirkland & Ellis Advises GTCR and Actient Holdings LLC in $585 Million Acquisition

Kirkland & Ellis LLP represents GTCR and its portfolio company Actient Holdings LLC, a private urology specialty therapeutics company, in Actient's $585 million acquisition by Auxilium Pharmaceuticals, Inc. The Chicago-based corporate team is led by partners Sanford Perl, Michael Weed and Michael Snow.

To read more about the transaction, please click here.